dismiss

Clean Sweep Live Auction on Wed. January 30th. Click to view the full inventory

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

CT Homepage

Belgium hospital implements Aidoc's AI neuro solution Integrated into GE PACS without changes to workflow

University of Cincinnati awarded $3.2 million to study stroke recurrence CT and MR images will be used to determine risk

Study calls for more consistent standards to lower dose variation Suggests large variations due to use of machine by different medical staffs

US Radiology Specialists partners with Touchstone Medical Imaging Contributes to US Radiology's 300 percent growth rate in less than a year

JLK Inspection unveils AIHuB Detects and monitors over 30 conditions in 14 body regions

New AI system classifies hemorrhages using small data sets Can explain reasoning behind decisions

New technique could reduce dose exposure during 3D X-ray exams Weighing the potential value of ghost imaging

Hitachi unveils new CT scanner, Scenaria View 128, at RSNA Provides better workflow with SynergyDrive and large, 80 cm aperture

Spectrum Dynamics files lawsuit against GE Alleges theft of intellectual property regarding VERITON-CT

MaxQ AI rolling out machine learning application for intercranial hemorrhage Part of a 'three-pronged' platform to improve stroke treatment

Progenics offers Curium exclusive license
to distribute its imaging agent, PyL

Progenics Pharmaceuticals selects Curium as European distributor of PyL

by John R. Fischer , Staff Reporter
Progenics Pharmaceuticals has selected Curium to be the distributor of its PSMA-targeted small molecule PET/CT imaging agent, PyL, in Europe.

The oncology company has granted an exclusive license to Curium to develop, and oversee regulatory approval and commercialization of the tracer, which is currently in Phase 3 development and designed to visualize prostate cancer.

Story Continues Below Advertisement

RaySafe helps you avoid unnecessary radiation

RaySafe solutions are designed to minimize the need for user interaction, bringing unprecedented simplicity & usability to the X-ray room. We're committed to establishing a radiation safety culture wherever technicians & medical staff encounter radiation.



“Curium is a world-class leader in nuclear medicine and an ideal partner for PyL, with the infrastructure, commercial footprint and experience in prostate cancer to position PyL for success in Europe,” Mark Baker, CEO of Progenics, said in a statement. “This collaboration accelerates development of PyL in this important market, while we focus our internal efforts on advancing our Phase 3 CONDOR trial and laying the groundwork for commercialization in the United States.”

A nuclear medicine manufacturer, Curium recently partnered with RadioMedix to develop and commercialize 64Cu-Dotatate, a tracer with a 12-hour half-life that can be used to identify suspected neuroendocrine tumors during PET exams.

It also expanded its European footprint to 25 sites back in May with the acquisition of PET diagnostics maker, Cyclopharma. The move expanded its French network to 13 radiopharmacies.

The addition of the distribution rights for PyL to the Curium portfolio is a classic example of its initiative to continue growing and expanding its portfolio of nuclear medicine diagnostics, according to Curium CEO Renaud Dehareng.

“PyL has the potential to detect small lesions, offering significant advantages over existing products and others in development,” he said. “We look forward to leveraging our success with F-Choline in prostate cancer to advance the development and commercial uptake of this next-generation product.”

Curium is set to meet with European regulators in the first half of 2019 to determine an agreed-upon regulatory path.

Progenics is entitled to royalties on net sales.

CT Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.
ALL RIGHTS RESERVED